Search form
Search
Login
Subscribe
Home
Country Intelligence
Industry Directory
Offsets / IC
Tenders
Australia
(19/week)
Haiti
(0/week)
Guyana
(0/week)
Honduras
(0/week)
Guatemala
(0/week)
View all
(19/week)
News
United States
(450/week)
Manufacturing
(348/week)
Technology
(352/week)
Energy
(230/week)
Other Manufacturing
(292/week)
Events
About us
Who we are
Our People
Partners
Contact us
LinkedIn
Login
Twitter
Register
Home
News
Blueprint Medicines
Sep 14, 2020
PANTHERx® Rare Pharmacy Selected by Blueprint Medicines to Distribute GAVRETO(TM) (pralsetinib) for the Treatment of Adults with Metastatic RET Fusion-Positive Non-Small Cell Lung Cancer (NSCLC)
Dec 10, 2019
CStone announces enrollment target reached in the global Phase III VOYAGER trial of avapritinib in Chinese patients with third-line GIST
Nov 06, 2019
Blueprint Medicines to Present Initial Data from Phase 2 PIONEER Trial of Avapritinib in Patients with Indolent Systemic Mastocytosis at 61st ASH Annual Meeting and Exposition
Nov 05, 2019
Blueprint Medicines Outlines Precision Therapy Research Vision, Provides Update on Discovery and Clinical-Stage Portfolio at R&D Day and Reports Third Quarter 2019 Financial Results
Aug 13, 2019
CStone announces first patient dosed in China with BLU-667 for the global Phase I registrational study
Aug 07, 2019
Blueprint Medicines Announces FDA Acceptance of New Drug Application for Avapritinib for the Treatment of PDGFRA Exon 18 Mutant GIST and Fourth-Line GIST
Aug 06, 2019
Blueprint Medicines to Present at 2019 Wedbush PacGrow Healthcare Conference
Aug 01, 2019
Blueprint Medicines Reports Second Quarter 2019 Financial Results
Jul 25, 2019
Blueprint Medicines to Report Second Quarter 2019 Financial Results on Thursday, August 1, 2019
Jul 09, 2019
CStone announces first patient dosed in China with avapritinib in global Phase III clinical trial in advanced GIST
Jun 15, 2019
Blueprint Medicines Presents Updated EXPLORER Trial Data for Avapritinib in Patients with Systemic Mastocytosis at 24th EHA Congress
Jun 14, 2019
Blueprint Medicines Submits New Drug Application to U.S. Food and Drug Administration for Avapritinib for the Treatment of PDGFRA Exon 18 Mutant GIST and Fourth-Line GIST
Jun 03, 2019
Blueprint Medicines' Highly Selective RET Inhibitor BLU-667 Shows Durable Anti-Tumor Activity in Patients with RET-Altered Cancers in Updated ARROW Trial Data Presented at ASCO 2019
May 08, 2019
Blueprint Medicines to Present at Bank of America Merrill Lynch 2019 Health Care Conference
May 02, 2019
Blueprint Medicines to Report First Quarter 2019 Financial Results on Thursday, May 9, 2019
Apr 15, 2019
CStone received IND approval in China for avapritinib Phase I/II bridging registrational study in patients with advanced gastrointestinal stromal tumors
Apr 02, 2019
Blueprint Medicines Announces Closing of Public Offering and Full Exercise of Option to Purchase Additional Shares of Common Stock
Mar 28, 2019
Blueprint Medicines Announces Pricing of Public Offering of Shares of Common Stock
Mar 27, 2019
Blueprint Medicines Announces Proposed Public Offering of Shares of Common Stock
Mar 27, 2019
Blueprint Medicines Announces Accelerated Regulatory Submission Plans and Recent Clinical Progress
Page 1
››
Latest News
Mar 29, 2024
Dubai Electricity and Water Authority PJSC Shareholders Approve Payment of AED 3.1 Billion in Dividends
Mar 29, 2024
Prevalon Energy Secures Contract with Idaho Power for New Integrated Battery Energy Storage System (BESS)
Mar 29, 2024
Element Solutions Inc to Participate in an Electronics Q&A Session Hosted by Goldman Sachs
Mar 29, 2024
Leading Independent Proxy Advisory Firms ISS and Glass Lewis Recommend U. S. Steel Shareholders Vote “FOR”...
Mar 29, 2024
Elevate Your Sales Skills with BRS Roofing Supply's Exclusive Bootcamp Featuring Expert Taylor McCarthy
Mar 29, 2024
AC Direct Announces NASCAR Sponsorship of Greg Van Alst
Mar 29, 2024
The Next Chapter for Bell’s H-1 Helicopters Begins
Mar 29, 2024
The Next Chapter for Bell’s H-1 Helicopters Begins
View all News
Agenda
17
June
France
Parc des Expositions de Paris Nord Villepinte ZAC Paris Nord 2, 93420 Villepinte – France (Halls 5a – 5b – 6)
Eurosatory 2024, 17 - 21 June 2024, Parc des Expositions de Paris Nord Villepinte ZAC Paris Nord 2, 93420 Villepinte – France (Halls 5a – 5b – 6)
Eurosatory 2024 There can be no sustainable world without peace and security. Founded in 1967, the exhibition...
21
May
Paris Marriott Rive Gauche & Conference Center
Future Artillery, 21-23 May 2024, Paris Marriott Rive Gauche & Conference Center, France
DELIVERING FIRES IN THE MULTI-DOMAIN BATTLESPACE As artillery reasserts itself as the ‘King of Battlefield’ in the wake...
21
May
United Arab Emirates
ADNEC (Abu Dhabi National Exhibition Centre), Abu Dhabi, Al Khaleej Al Arabi St - Al Rawdah - Al Ma'arid - Abu Dhabi, UAE
ISNR Abu Dhabi 2024, 21-23 May 2024, ADNEC (Abu Dhabi National Exhibition Centre), Abu Dhabi, Al Khaleej Al Arabi St - Al Rawdah - Al Ma'arid - Abu Dhabi, UAE
ISNR ACCELERATING TRANSFORMATION IN THE NATIONAL SECURITY ECOSYSTEM ISNR Abu Dhabi is the region’s most trusted...
View All Events